Understanding the treatment affordability of high-cost SCD therapies in Egypt, India, Nigeria and Pakistan Read more
Gaining an understanding of the reimbursement landscape and access potential for a new treatment for the treatment of migraine Read more
Strategic Assessment of the Multiple Sclerosis Market to Define Price and Access Potential for 4 Innovators in Emerging Markets Including South Africa Read more
In-depth Analysis of New Products in Multiple Sclerosis to Understand Product Positioning and Associate Product Potential in Key MEA Geographies Read more
Understanding Risks for Biosimilars in the MEA Region, and Associated Entry List and Net Prices Read more
Conjoint Analysis Assessment for Payer and Physician Pricing and Access Decision Making Drivers in Rheumatoid Arthritis Read more
Conducting a Market Research Study to Understand the Cost Implication and Potential Benefits of the Introduction of an IPV-containing Hexavalent Vaccine to the Childhood Vaccine Schedule Read more
Conjoint Analysis Assessment for Payor & Physician Pricing and Access Decision Making Drivers in Rheumatoid Arthritis Read more
